Legend Biotech Corp (LEGN) Net income 2018–2025
Legend Biotech Corp (LEGN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$296.8MFY2025 · since FY2018: -$2.8M → -$296.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$296.8M | -67.7% |
| FY2024 | -$177.0M | +65.8% |
| FY2023 | -$518.3M | -16.1% |
| FY2022 | -$446.3M | -10.6% |
| FY2021 | -$403.6M | -51.5% |
| FY2020 | -$266.4M | -162.2% |
| FY2019 | -$101.6M | -3549.1% |
| FY2018 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LEGN financial trends
LEGN RevenueLEGN Net marginLEGN Gross profitLEGN Gross marginLEGN Operating incomeLEGN Operating marginLEGN Operating cash flowLEGN Free cash flowLEGN Capital expendituresLEGN Return on equityLEGN Stock buybacksLEGN Dividends paidLEGN Total assetsLEGN Total liabilitiesLEGN Shareholders’ equityLEGN overview →